# Acurx Pharmaceuticals, Inc.: Form 8-K, filed May 17, 2023

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: 8-K
- Filed: 2023-05-17
- Accepted by EDGAR: May 17, 2023, 16:19 ET
- Period: 2023-05-16
- Accession: 0001104659-23-061848
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465923061848/tm2315976d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465923061848/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465923061848/tm2315976d1_8k.htm

Filed May 17, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-061848. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
